Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
CALQUENCE Kaps 100 mg 60 Stk
Drug
Calquence, Hartkapseln
chronisch lymphatische Leukämie (CLL)
07.16.1. – cytostatics
HAM – Human medicine
KAHA – Capsule, hard
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
3/4/2021
3/3/2026
Dosage strength
Calquence 100 mg, Hartkapseln
chronisch lymphatische Leukämie (CLL)
01
Z – approved
Package
7680677900013
No information made available
A/R – Authorised / referenced
60 capsule(s)
001
Z – approved
Declaration
Component
100 mg acalabrutinibum
cellulosum microcristallinum silicificatum
amylum pregelificatum
carboxymethylamylum natricum A
max. 0.25 mg natrium
magnesii stearas
gelatina
E 172 (flavum)
E 132
E 171
lacca
E 172 (nigrum)
propylenglycolum
ammonii hydroxidum
amylum pregelificatum
carboxymethylamylum natricum A
max. 0.25 mg natrium
magnesii stearas
gelatina
E 172 (flavum)
E 132
E 171
lacca
E 172 (nigrum)
propylenglycolum
ammonii hydroxidum
Spezialitätenliste***
SL
-
-
4939.55
None
Yes
10%
No
Authorisation holder
7601001348622
AstraZeneca AG
Neuhofstrasse 34
6340 Baar (ZG)
Neuhofstrasse 34
6340 Baar (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.